Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Shenzhen Neptunus Pharmaceutical Co., Ltd.
Oxaliplatin
Indication: Combined with 5-fluorouracil and folinic acid (leucovorin): first-line treatment of metastatic colorectal cancer; adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of the primary tumor. This indication is based on the results of foreign clinical studies.
Manufacturer:
Simcere Pharmaceutical Co., Ltd.
Doxifluridine
Indication: This product is used for gastric cancer, colon cancer, rectal cancer, breast cancer, cervical cancer, and bladder cancer.
Manufacturer:
Zibo Wanjie Pharmaceutical Co., Ltd.
Doxifluridine
Indication: Stomach cancer, colon cancer, rectal cancer, breast cancer, cervical cancer, bladder cancer.
Manufacturer:
Southwest Synthetic Pharmaceutical Corp.,ltd.
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Manufacturer:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Doxifluridine Capsules
Indication: Used to treat breast cancer, gastric cancer, colorectal cancer, and nasopharyngeal cancer.
Manufacturer:
Shanghaizhaohui Pharmaceutical Co., Ltd.
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Manufacturer:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Manufacturer:
Hainan General Alliance Pharmaceutical Co., Ltd.
Doxifluridine Capsules
Indication: This product is used to treat breast cancer, gastric cancer, colorectal cancer, nasopharyngeal cancer, and cervical cancer.
Related Ingredients